XML 26 R75.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segments (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Segment Reporting Information [Line Items]        
Revenues $ 84,331,000 $ 64,439,000 $ 223,858,000 $ 182,604,000
Cost of Revenue 38,244,000 29,991,000 102,646,000 82,699,000
Gross profit 46,087,000 34,448,000 121,212,000 99,905,000
Gross Margin Percentage 54.70% 53.50% 54.10% 54.70%
Operating Expenses 34,861,000 29,654,000 103,920,000 89,852,000
Income from operations 11,226,000 4,794,000 17,292,000 10,053,000
Operating margin percentage 13.30% 7.40% 7.70% 5.50%
Interest and other income (expense), net 34,000 (191,000) 57,000 (66,000)
Income before provision for income taxes 11,260,000 4,603,000 17,349,000 9,987,000
Provision for income taxes 4,340,000 1,609,000 6,703,000 3,736,000
Net income 6,920,000 2,994,000 10,646,000 6,251,000
Acute Care Solutions [Member]
       
Segment Reporting Information [Line Items]        
Revenues 64,394,000 64,439,000 191,294,000 182,604,000
Cost of Revenue 26,920,000 29,991,000 82,858,000 82,699,000
Gross profit 37,474,000 34,448,000 108,436,000 99,905,000
Gross Margin Percentage 58.20% 53.50% 56.70% 54.70%
Operating Expenses 29,070,000 29,654,000 94,167,000 89,852,000
Income from operations 8,404,000 4,794,000 14,269,000 10,053,000
Operating margin percentage 13.10% 7.40% 7.50% 5.50%
Non-acute care solutions [Member]
       
Segment Reporting Information [Line Items]        
Revenues     32,564,000  
Cost of Revenue 11,324,000   19,788,000  
Gross profit 8,613,000   12,776,000  
Gross Margin Percentage 43.20%   39.20%  
Operating Expenses 5,791,000   9,753,000  
Income from operations 2,822,000   3,023,000  
Operating margin percentage 14.20%   9.30%  
MTS-Medication Technologies [Member]
       
Segment Reporting Information [Line Items]        
Revenues 18,300,000      
MTS-Medication Technologies [Member] | Non-acute care solutions [Member]
       
Segment Reporting Information [Line Items]        
Revenues     19,937,000  
Net income     1,929,000  
COS relief of FV inventory step-up and misc [Member] | MTS-Medication Technologies [Member] | Non-acute care solutions [Member]
       
Segment Reporting Information [Line Items]        
Cost of Revenue 0   1,650,184  
Acq trransaction costs [Member] | MTS-Medication Technologies [Member] | Acute Care Solutions [Member]
       
Segment Reporting Information [Line Items]        
Operating Expenses 0   2,342,780  
Severance and misc cost [Member] | MTS-Medication Technologies [Member] | Non-acute care solutions [Member]
       
Segment Reporting Information [Line Items]        
Operating Expenses 0   861,828  
Acquisition-related Costs [Member] | Acute Care Solutions [Member]
       
Segment Reporting Information [Line Items]        
Cost of Revenue     2,300,000  
Acquisition-related Costs [Member] | Non-acute care solutions [Member]
       
Segment Reporting Information [Line Items]        
Cost of Revenue     900,000  
Fair Value Adjustment to Inventory [Member] | Non-acute care solutions [Member]
       
Segment Reporting Information [Line Items]        
Cost of Revenue     $ 1,700,000